New York City Metropolitan Area
Results-driven insights/analytics and commercial strategy leader with strong management experience. Deep and broad expertise fostered over 20+ years with Novartis, Biogen, and as a biopharma consultant. Prior roles in strategy development, market research, competitive intelligence, analytics, and new product planning Developed and executed insight-driven strategies in numerous therapeutic categories, including oncology, rare diseases, neurology, inflammation/immunology, cardio-metabolic, infectious diseases, and others. Areas of expertise: Market Research | Competitive Intelligence/Competitive Strategy | Analytics & Forecasting | US and Global | Pipeline, Launch, and In-line Products | Brand Marketing | Strategic Planning
Drive integration of insights across four Insights & Analytics functions, while managing the US Business Intelligence team to deliver performance reporting. • Lead cross-functional analyses of primary, secondary, and database data, distilling into critical insights, and synthesizing findings into clear, compelling, persuasive narratives. • Regularly merge key findings from market research and data analytics to address business needs. • Lead the development of appropriate metrics and implementing KPI reporting for competitor tracking, digital marketing, and other needs.
Led internal stakeholders in shaping clinical development plans and marketing strategies for neurology, immunology, and psychiatry assets. • Established or refined data- and insight-driven analyses of treatment pathways, unmet medical needs, and market landscapes; then aligned internal stakeholders on implications. • Drove cross-functional commercialization of pipeline assets: generating commercial assessments, positioning, value propositions, HCP and patient journeys, target product profiles, and competitive strategies for several assets. • Partner with R&D and Medical to leverage insights in developing medical strategies and evidence generation plans.
Directed a market research and competitive intelligence (CI) team for a portfolio of Alzheimer’s disease assets. Partnered with other senior leaders on strategic plans, market forecasts, driving launch excellence, and other key deliverables. • Oversaw planning, execution, and synthesis of market research and CI for launch and pipeline assets. Engaged cross-functionally and directed vendors in ensuring that customer, competitor, and industry insights were infused into marketing plans. • Drove insight-and-analytics input into life cycle strategic plans and annual brand plans, refining as needed based on market landscape changes. • Led refinement of strategic frameworks, e.g. situation analyses, market maps, and patient journeys. • Oversaw COE initiatives to standardize best practices and ensure efficient use of resources. • Partnered with Analytics to craft assumptions on epidemiology, market trends, product profiles, etc. • Delivered multiple global and cross-region key initiatives, e.g. identification and alignment on KPIs.
Advised clients on biopharma marketing strategy and tactics, market research, brand planning, and BD. • Led or managed strategic projects including market analyses and repositioning for multiple brands, including in oncology, rare diseases, vaccines, and anti-infectives. • Co-developed launch plans for two rare disease biotechs: guided strategy development, led tactical ideation work sessions, and managed finalization of plans. • Shaped pre-launch and inline efforts for multiple brands: e.g. positioning, patient journeys, messaging, analytics for epidemiology-based forecasts, and promotion response models. Regularly crafted supporting market research plans, executed the research, and interpreted results. • Coordinated DTC response analysis among a big pharma client, IQVIA, and 2 media companies.
As an ad agency marketing strategist, routinely managed multiple strategic projects across biopharma clients. Supervised and developed numerous direct reports. • Led marketing strategy activities for ~20 products: market analyses, positioning, customer journeys, messaging, war games, campaigns, market research, brand planning, etc. • Managed positioning efforts from ideation through final recommendations, for brands in oncology, GI, diabetes, antibiotics, psychiatry, neurology, and others. • Established brand strategy frameworks and market research processes of several small, emerging companies. • Constructed a data-driven analysis that persuaded a client’s senior executives to reverse a decision on a launch campaign. • US and global experience with pipeline, launch, and marketed brands. • Strong experience with HCPs, patients/caregivers, advocacy groups, and payers. DDB HEALTH | GREY GROUP | H4B CHELSEA | TRIBAL DDB